Mandate

Vinge advised Ernström & C:o

December 02, 2017 M&A

Vinge has advised Ernström & C:o in conjunction with the investment and acquisition of shares in CellMark Investment.

Ernström is a Gothenburg-based investment company which is owned by the Hobohm Hielte family. CellMark is a global trading house within chemicals, paper, pulp, metals, packaging, recycling, energy and pharmaceuticals. Ernström has acquired almost one quarter of CellMark.

Vinge’s team consisted of responsible partner Olof Jisland together with associates Filip Öhrner, Daniel Lennartsson, André Isacson, Sara Strandberg, Filip Markhed and VDR assistant Sofie Sundin.

Related

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024